Hypertensive Emergency Management

Definition and Diagnosis

• A blood pressure exceeding 180/120 mmHg with evidence of target organ damage is classified as a hypertensive emergency requiring immediate intervention and ICU admission, according to the American College of Cardiology and the European Heart Journal 1, 2, 3
• Hypertensive emergencies are characterized by severe BP elevations (>180/120 mmHg) associated with evidence of new or worsening target organ damage, as stated by the American Heart Association 3
• The presence of target organ damage is the critical differentiating factor between a hypertensive emergency and other forms of severe hypertension, as noted by the European Heart Journal 4
• Without treatment, hypertensive emergencies carry a 1-year mortality rate >79% and median survival of only 10.4 months, according to the American Heart Association 3

Types of Target Organ Damage

• Target organ damage in hypertensive emergencies may include hypertensive encephalopathy, intracranial hemorrhage, acute myocardial infarction, acute left ventricular failure, dissecting aortic aneurysm, acute renal failure, eclampsia, and advanced retinopathy, as listed by the European Heart Journal and the American Heart Association 3, 4

Management Approach

• Admission to an intensive care unit is recommended (Class I, Level B-NR) for patients with hypertensive emergencies, according to the American College of Cardiology and the American Heart Association 2, 3
• Continuous monitoring of BP and target organ damage is essential, as stated by the American Heart Association 3
• Parenteral administration of appropriate antihypertensive agents is required, according to the American College of Cardiology 2
• The American College of Cardiology recommends reducing SBP to <140 mmHg during the first hour for patients with compelling conditions, and further reducing SBP to <120 mmHg for patients with aortic dissection 2, 3
• For patients without compelling conditions, the American College of Cardiology recommends reducing SBP by no more than 25% within the first hour, and then cautiously reducing to normal during the following 24-48 hours 2, 3

Medication Selection

• First-line IV medications for hypertensive emergencies include nicardipine, clevidipine, sodium nitroprusside, and labetalol, as recommended by the American Heart Association 3
• The American Heart Association provides dosage guidelines for these medications, including initial doses and titration instructions 3

Important Clinical Considerations

• The actual BP level may not be as important as the rate of BP rise, and patients with chronic hypertension often tolerate higher BP levels than previously normotensive individuals, as noted by the American Heart Association 3
• Excessive falls in pressure that may precipitate renal, cerebral, or coronary ischemia should be avoided, according to the American Heart Association 5
• Treatment should be tailored to the specific type of organ damage present, as recommended by the European Heart Journal 4

Management of Acute Hypertension with Renal and Brain Ischemia

Pathophysiological Relationship

• Acute severe hypertension disrupts cerebral and renal autoregulation, leading to ischemia through microvascular damage with endothelial dysfunction causing thrombotic microangiopathy, according to the European Society of Cardiology 6, 7
• In malignant hypertension, activation of the renin-angiotensin system is highly variable, making blood pressure response to medications unpredictable and potentially dangerous, as noted by the European Society of Cardiology 6

Clinical Manifestations

• Renal ischemia presents as acute kidney injury with potential thrombotic microangiopathy in the setting of malignant hypertension, as reported by the European Society of Cardiology 6, 7
• Brain ischemia can manifest as hypertensive encephalopathy with altered mental status, headache, and visual disturbances, according to the European Society of Cardiology 6, 7
• Ischemic stroke can occur if blood pressure is lowered too rapidly or excessively, as noted by the European Society of Cardiology 8

Treatment Approach

• The European Society of Cardiology recommends intravenous labetalol as first-line treatment for malignant hypertension with renal failure, targeting a 20-25% reduction in mean arterial pressure over several hours 6, 8
• For hypertensive encephalopathy, the European Society of Cardiology recommends immediate reduction of mean arterial pressure by 20-25% using intravenous labetalol 6, 7
• In acute ischemic stroke with hypertension, the European Society of Cardiology advises avoiding blood pressure reduction within the first 5-7 days unless blood pressure exceeds 220/120 mmHg 8
• For acute hemorrhagic stroke, careful reduction of systolic blood pressure to <180 mmHg may be considered for systolic blood pressure >220 mmHg, as reported by the European Society of Cardiology 9

Medication Selection

• Labetalol is the first-line agent for most hypertensive emergencies involving brain or kidney ischemia, according to the European Society of Cardiology 6, 7, 8
• ACE inhibitors should be started at very low doses due to unpredictable responses, as noted by the European Society of Cardiology 6, 7

Important Clinical Considerations

• Volume depletion from pressure natriuresis may occur, and intravenous saline may be needed to correct precipitous blood pressure falls, as reported by the European Society of Cardiology 7
• After stabilization, transition to oral antihypertensive therapy should be gradual, according to the European Society of Cardiology 6

Management of Acute Hypertension Caused by Renal and Brain Ischemia

Treatment Approach

• For acute ischemic stroke: avoid blood pressure reduction within the first 5-7 days unless blood pressure exceeds 220/120 mmHg, as recommended by the European Society of Cardiology 10
• For acute hemorrhagic stroke: carefully lower systolic BP to 140-160 mmHg if presenting with systolic BP ≥220 mmHg, according to the European Heart Journal guidelines 10
• For ischemic stroke patients eligible for reperfusion therapy: BP should be carefully lowered and maintained at <180/105 mmHg for at least the first 24 hours after treatment, as suggested by the European Heart Journal 10
• For ischemic stroke patients not receiving reperfusion treatment with BP ≥220/110 mmHg: BP should be carefully lowered by approximately 15% during the first 24 hours after stroke onset, based on the European Heart Journal recommendations 10
• For intracerebral hemorrhage: immediate BP lowering (within 6 hours of symptom onset) to a systolic target of 140-160 mmHg to prevent hematoma expansion, as recommended by the European Heart Journal 10
• Excessive acute drops in systolic BP (>70 mmHg) may be associated with acute renal injury and early neurological deterioration, according to the European Heart Journal 10
• Screening for secondary hypertension is recommended after stabilization, as patients with hypertensive emergencies remain at high risk, as stated by the European Heart Journal 10
• For stable patients who remain hypertensive (≥140/90 mmHg) ≥3 days after an acute ischemic stroke, initiation or reintroduction of BP-lowering medication is recommended, based on the European Heart Journal guidelines 10
• The survival of patients with hypertensive emergencies has improved over the past few decades with proper management, as reported by the European Heart Journal 10

Laboratory Evaluation in Hypertensive Emergency

Definition and Clinical Context

• Hypertensive emergency is defined as severe blood pressure elevation (>180/120 mmHg) with evidence of new or worsening target organ damage, according to the American Heart Association 11, 12

Essential Laboratory Tests

• A comprehensive laboratory panel should include hemoglobin, platelets, creatinine, sodium, potassium, lactate dehydrogenase (LDH), haptoglobin, urinalysis for protein, and urine sediment to assess target organ damage and guide management, as recommended by the American College of Cardiology 13, 14
• Complete blood count (hemoglobin, platelets) to assess for evidence of microangiopathic hemolytic anemia, with a strength of evidence level of B, according to the American Heart Association 13, 14
• Basic metabolic panel including creatinine, sodium, and potassium to evaluate renal function and electrolyte abnormalities, with a strength of evidence level of A, according to the American College of Cardiology 13, 14
• Lactate dehydrogenase (LDH) and haptoglobin to detect hemolysis in hypertensive thrombotic microangiopathy, with a strength of evidence level of B, according to the American Heart Association 13, 14
• Urinalysis for protein and urine sediment examination to identify renal damage, with a strength of evidence level of A, according to the American College of Cardiology 13, 14
• Troponins for patients with chest pain to evaluate for acute coronary syndrome, with a strength of evidence level of A, according to the American College of Cardiology 13, 14
• Electrocardiogram (ECG) to assess for cardiac involvement, with a strength of evidence level of B, according to the American Heart Association 13, 14

What to Look For in Laboratory Results

• Elevated creatinine indicating acute kidney injury, with a strength of evidence level of A, according to the American College of Cardiology 13, 14
• Proteinuria and abnormal urine sediment suggesting renal damage, with a strength of evidence level of A, according to the American College of Cardiology 13, 14
• Thrombocytopenia and elevated LDH with decreased haptoglobin indicating thrombotic microangiopathy, with a strength of evidence level of B, according to the American Heart Association 13, 14
• Elevated troponins suggesting myocardial injury, with a strength of evidence level of A, according to the American College of Cardiology 12, 15

Organ-Specific Laboratory Evaluation

• Creatinine, BUN, electrolytes, and urinalysis to evaluate for acute kidney injury, with a strength of evidence level of A, according to the American College of Cardiology 13, 14
• Significant proteinuria may indicate hypertensive nephropathy, with a strength of evidence level of B, according to the American Heart Association 13, 14
• Troponins and BNP for evidence of myocardial injury or heart failure, with a strength of evidence level of A, according to the American College of Cardiology 12, 15
• ECG to assess for left ventricular hypertrophy or ischemia, with a strength of evidence level of B, according to the American Heart Association 13, 14

Clinical Pitfalls to Avoid

• Do not delay laboratory testing in hypertensive emergency - immediate assessment is crucial for appropriate management, with a strength of evidence level of A, according to the American College of Cardiology 11, 12
• Remember that laboratory findings must be interpreted in the clinical context - not all abnormalities are directly related to the hypertensive crisis, with a strength of evidence level of B, according to the American Heart Association 13, 14
• Do not overlook the possibility of secondary hypertension, which requires specific diagnostic workup after stabilization, with a strength of evidence level of B, according to the American Heart Association 13, 14

Management of Hypertensive Emergency

Initial Assessment and Management

• Admitting a patient with hypertensive emergency to an intensive care unit for continuous blood pressure monitoring and parenteral antihypertensive administration is recommended by the American Heart Association 16
• Avoiding excessive blood pressure reduction, which can precipitate ischemic events in the brain, heart, or kidneys, is crucial in managing hypertensive emergencies 16

Medication Selection

• Nicardipine is particularly effective with a rapid onset of action and duration, allowing for careful titration, and is recommended for hypertensive emergencies 16
• Labetalol is an excellent choice for hypertensive emergencies with renal involvement, according to the American College of Cardiology 16
• Avoiding short-acting nifedipine due to its potential to cause unpredictable blood pressure reduction and reflex tachycardia is recommended 16

Long-term Management

• Transitioning to oral antihypertensive therapy with a combination of RAS blockers, calcium channel blockers, and diuretics is recommended by the European Society of Cardiology 17
• Targeting systolic blood pressure to 120-129 mmHg for most adults to reduce cardiovascular risk is recommended by the European Society of Cardiology 17
• Fixed-dose single-pill combination treatment is recommended for long-term management of hypertensive patients by the European Society of Cardiology 17

Hypertensive Emergency Management

Definition and Diagnosis

• A hypertensive emergency is defined as severely elevated blood pressure associated with acute hypertension-mediated organ damage requiring immediate intervention to prevent progressive organ failure, characterized by the presence of target organ damage rather than by specific blood pressure thresholds 18
• Secondary causes are found in 20-40% of patients with malignant hypertension 19
• Contributing factors include use of sympathomimetics, cocaine, NSAIDs, steroids, immunosuppressants, and antiangiogenic therapy 18, 20
• Presentations vary based on the affected organ systems, with common symptoms including headache, visual disturbances, chest pain, dyspnea, neurological symptoms, and dizziness 18, 20
• Specific clinical presentations include malignant hypertension, hypertensive encephalopathy, hypertensive thrombotic microangiopathy, and other presentations such as cerebral hemorrhage, acute stroke, acute coronary syndrome, cardiogenic pulmonary edema, aortic dissection, and severe preeclampsia/eclampsia 18

Diagnostic Evaluation

• Thorough history should assess preexisting hypertension, onset and duration of symptoms, and potential causes 18, 20
• Physical examination should focus on cardiovascular and neurological assessment 18, 20
• Essential laboratory tests include complete blood count, renal function tests, lactate dehydrogenase, haptoglobin, urinalysis, and troponins in patients with chest pain 18, 19
• Additional investigations based on clinical presentation include fundoscopy, ECG, chest X-ray, echocardiogram, CT/MRI brain, and CT-angiography thorax/abdomen 18, 19

Treatment and Management

• First-line IV medications based on specific presentations include labetalol, nicardipine, or clevidipine for malignant hypertension, and immediate MAP reduction by 20-25% using labetalol or nicardipine for hypertensive encephalopathy 18
• Treatment goals vary by specific organ damage, with a general approach to reduce mean arterial pressure by 20-25% within the first hour, except in specific conditions 18
• Acute ischemic stroke with BP >220/120 mmHg requires MAP reduction by 15% within 1 hour, while acute coronary event requires nitroglycerin with target SBP <140 mmHg immediately 18
• Acute cardiogenic pulmonary edema requires nitroprusside or nitroglycerin with target SBP <140 mmHg immediately, and acute aortic disease requires esmolol plus nitroprusside/nitroglycerin with target SBP <120 mmHg and heart rate <60 bpm immediately 18

Potential Complications

• Cerebral complications include hypertensive encephalopathy, ischemic or hemorrhagic stroke 18
• Cardiac complications include acute myocardial infarction, acute left ventricular failure 18
• Renal complications include acute kidney injury, thrombotic microangiopathy 18
• Vascular complications include aortic dissection or rupture 18
• Ocular complications include advanced retinopathy with potential vision loss 18

Hypertensive Emergency Management

Immediate Priorities

• The European Heart Journal recommends admitting patients with hypertensive emergency to the ICU immediately for continuous BP monitoring and parenteral therapy, with a target BP reduction of 20-25% in the first hour 21
• The European Heart Journal suggests avoiding reducing BP to normal in the acute phase, as patients with chronic hypertension have altered autoregulation and acute normotension can cause cerebral, renal, or coronary ischemia 21

Medication Management

• The Journal of Clinical Oncology recommends using antipyretics, such as acetaminophen, for symptomatic fever management 22
• The European Heart Journal recommends using nicardipine infusion at 5 mg/hr, titrating by 2.5 mg/hr every 15 minutes, with a maximum of 15 mg/hr, to achieve a target BP reduction of 20-25% in the first hour 21

Monitoring Requirements

• The European Heart Journal recommends arterial line placement for continuous BP monitoring in the ICU 21

Follow-up After Stabilization

• The European Heart Journal recommends screening for secondary hypertension causes, such as renal artery stenosis, pheochromocytoma, or primary aldosteronism, as 20-40% of malignant hypertension cases have secondary causes 21
• The European Heart Journal suggests addressing medication non-compliance, the most common trigger for hypertensive emergencies 21

Hypertensive Crisis Management

Definition and Classification

• Hypertensive crisis is an umbrella term encompassing both hypertensive emergencies and hypertensive urgencies, with hypertensive emergency specifically referring to severely elevated blood pressure (>180/120 mmHg) with acute target organ damage requiring immediate intervention, as defined by the American Heart Association 23, 24
• The presence of acute organ damage—not the absolute BP number—is the critical distinguishing feature between hypertensive emergency and hypertensive urgency, according to the European Society of Cardiology 25, 24

Clinical Significance and Target Organ Damage

• The rate of BP rise may be more important than the absolute BP level, with patients with chronic hypertension often tolerating higher pressures than previously normotensive individuals, as noted by the American College of Cardiology 23
• Examples of acute target organ damage defining a hypertensive emergency include neurologic (hypertensive encephalopathy, intracranial hemorrhage, acute ischemic stroke), cardiac (acute myocardial infarction, acute left ventricular failure with pulmonary edema, unstable angina), vascular (aortic dissection or aneurysm), renal (acute kidney injury, hypertensive thrombotic microangiopathy), ophthalmologic (malignant hypertension with advanced retinopathy), and obstetric (severe preeclampsia or eclampsia) complications 23, 24

Management Implications

• Hypertensive emergency requires ICU admission (Class I recommendation, Level B-NR) for continuous BP and target organ monitoring, and demands immediate parenteral (IV) therapy with titratable short-acting agents, as recommended by the European Society of Cardiology 23, 25
• Target BP reduction for hypertensive emergency should aim to reduce SBP by no more than 25% within the first hour, then if stable to 160/100 mmHg over 2-6 hours, then cautiously to normal over 24-48 hours, with more aggressive targets for compelling conditions such as aortic dissection or severe preeclampsia/eclampsia 23

Management of Hypertensive Emergencies with Acute Pulmonary Edema

Diagnostic Assessment and Treatment

• The American Heart Association suggests that the combination of sudden dyspnea with hypertension indicates acute left ventricular failure with pulmonary edema, which is a hypertensive emergency requiring immediate intervention, with a recommended blood pressure reduction target of <140 mmHg immediately 26
• The American College of Cardiology recommends avoiding excessive acute drops in systolic BP (>70 mmHg) as this may precipitate acute renal injury, cerebral ischemia, or coronary ischemia, with a strength of evidence level of B-NR 26
• Nitroglycerin IV is the preferred first-line agent for hypertensive emergency with acute pulmonary edema, with a dosing regimen of 5-10 mcg/min IV infusion, titrated by 5-10 mcg/min every 5-10 minutes until desired BP reduction or symptom relief, and a mechanism of action that reduces preload and afterload, improves myocardial oxygen supply-demand ratio, and directly relieves pulmonary congestion 26
• Sodium nitroprusside can be used as an alternative to nitroglycerin, with a dosing regimen of 0.25-10 mcg/kg/min as IV infusion, and a caution for risk of thiocyanate toxicity with prolonged use (>48-72 hours) or renal insufficiency 26
• The American Heart Association recommends that short-acting nifedipine is contraindicated due to unpredictable precipitous blood pressure drops and reflex tachycardia that can worsen myocardial ischemia 26
• The American College of Physicians suggests that do not apply outpatient blood pressure goals to acute inpatient management, as the evidence for aggressive inpatient BP lowering is limited and may cause harm through hypotension-related complications 27

Hypertensive Emergency and Urgency Management

Initial Assessment and Triage

• The European Society of Cardiology recommends determining if a patient has a hypertensive emergency or urgency, with hypertensive emergency defined as BP >180/120 mmHg WITH acute target organ damage, requiring immediate ICU admission and IV therapy 28
• The American College of Physicians suggests that hypertensive urgency is characterized by severely elevated BP WITHOUT acute organ damage, and can be managed with oral medications and outpatient follow-up 29

Identify Target Organ Damage

• The European Society of Cardiology notes that hypertensive encephalopathy is a sign of target organ damage, characterized by altered mental status, headache, visual disturbances, and seizures, and requires immediate attention 28
• The European Society of Cardiology also recommends assessing for malignant hypertension, characterized by retinal hemorrhages, cotton wool spots, and papilledema on fundoscopy, which is a sign of target organ damage 28

Management Algorithm

• The European Society of Cardiology recommends avoiding excessive acute drops in systolic BP (>70 mmHg) as this may precipitate acute renal injury, cerebral ischemia, or coronary ischemia 28

Hypertensive Urgency Management

• The American College of Physicians suggests that patients with hypertensive urgency do not require hospital admission or IV medications, and can be managed with oral antihypertensive therapy and outpatient follow-up 29
• The American College of Emergency Physicians notes that up to one-third of patients with diastolic BP >95 mmHg normalize before follow-up, and rapid BP lowering may be harmful 30

Post-Stabilization Evaluation

• The European Society of Cardiology recommends screening for secondary hypertension causes, including pheochromocytoma, in patients with malignant hypertension 28
• The European Society of Cardiology also notes that many patients presenting with acute pain or distress have transiently elevated BP that normalizes when the underlying condition is treated, and recommends avoiding treatment of the BP number alone without assessing for true hypertensive emergency 28

Management of Severe Hypertension with Target Organ Damage

Introduction to Hypertensive Emergencies

• The European Heart Journal recommends that in cases of acute intracerebral hemorrhage, blood pressure should not be lowered immediately if systolic blood pressure is <220 mmHg; if systolic blood pressure ≥220 mmHg, it should be carefully lowered to <180 mmHg with IV therapy 31

Critical Management Considerations

• The European Heart Journal notes that reducing blood pressure too rapidly can cause cerebral, renal, or coronary ischemia in patients with chronic hypertension, due to altered autoregulation 32

Management of Hypertensive Emergency

Immediate Assessment and Triage

• The European Society of Cardiology recommends immediate intervention for hypertensive encephalopathy, a true hypertensive emergency requiring immediate intervention, characterized by severe hypertension with headache and multiple episodes of vomiting 33, 34
• The combination of neurological symptoms, such as headache, with vomiting indicates potential acute brain injury from severely elevated blood pressure, and a rapid neurological examination should be performed to assess for altered mental status, visual disturbances, seizures, or focal deficits 33, 34

First-Line Medication Selection

• The European Society of Cardiology recommends labetalol or nicardipine as the preferred first-line agents for hypertensive encephalopathy, with nicardipine offering superior advantages because it leaves cerebral blood flow relatively intact compared to other agents and does not increase intracranial pressure 33, 34
• Labetalol can be used as an alternative, with a dose of 0.25-0.5 mg/kg IV bolus, or 2-4 mg/min continuous infusion until goal BP is reached, then 5-20 mg/hr maintenance 33, 34

Blood Pressure Target

• The European Society of Cardiology recommends reducing mean arterial pressure by 20-25% within the first hour, with a target blood pressure of 160/100 mmHg over the next 2-6 hours if stable, and cautious normalization of blood pressure over 24-48 hours 33, 34
• Excessive acute drops in blood pressure (>70 mmHg systolic) can precipitate cerebral, renal, or coronary ischemia, and patients with chronic hypertension have altered cerebral autoregulation and cannot tolerate acute normalization of blood pressure 34

Monitoring Requirements

• The European Society of Cardiology recommends continuous monitoring of neurological status, including mental status, visual changes, and seizures, as well as heart rate, to watch for reflex tachycardia with nicardipine 33, 34

Critical Pitfalls to Avoid

• The American Heart Association recommends avoiding the use of immediate-release nifedipine, hydralazine, and sodium nitroprusside, unless other agents fail, due to their unpredictable effects and potential risks 34, 35
• The European Society of Cardiology recommends not lowering blood pressure to "normal" acutely, as this can cause ischemic complications, and not using oral medications for initial management, as hypertensive emergency requires IV therapy 34, 35

Hypertensive Emergency Diagnosis and Management

Clinical Presentation and Diagnosis

• The American Heart Association recommends immediate ER referral for patients with blood pressure >180/120 mmHg and evidence of acute target organ damage, such as neurologic, cardiac, vascular, renal, or ophthalmologic damage 36
• Patients with a history of diabetes mellitus, ischemic heart disease, or cerebrovascular accident have a higher risk of end-organ damage and warrant more aggressive screening 36
• A focused assessment for subtle signs of organ damage, including brief neurologic exam, cardiac assessment, and fundoscopic exam, is crucial in asymptomatic patients with severely elevated blood pressure 36

Special Populations and Management

• The American College of Cardiology suggests considering ER referral for high-risk patients, such as those with a history of diabetes mellitus, ischemic heart disease, or cerebrovascular accident, even with borderline symptoms or equivocal findings 36
• Patients with acute target organ damage, such as hypertensive encephalopathy, acute ischemic stroke, or intracranial hemorrhage, require immediate ER transfer and ICU admission 36

Assessment and Referral Algorithm

• The European Society of Cardiology recommends confirming blood pressure >180/120 mmHg with repeat measurement and assessing for symptoms suggesting organ damage, such as headache, visual changes, or chest pain 36
• A step-wise approach to assessment and referral, including focused exam and initiation of oral antihypertensives, is essential for managing patients with hypertensive emergencies 36

Management of Severe Hypertension

Initial Assessment and Management

• The American College of Physicians recommends managing hypertensive urgency with oral antihypertensive therapy and outpatient follow-up, without the need for hospital admission and IV medications, in the absence of target organ damage 37
• The American College of Physicians suggests arranging follow-up within 2-4 weeks to assess response to therapy, with a target blood pressure goal of <130/80 mmHg to <140/90 mmHg depending on patient characteristics 37

Special Considerations

• The American College of Physicians notes that current guidelines provide no specific recommendations for managing asymptomatic moderately elevated BP in hospitalized patients, and observational studies suggest intensive inpatient BP treatment may be associated with worse outcomes including acute kidney injury and stroke 37, 38

First-Line Treatment for Severe Hypertension

Critical Initial Assessment

• The American College of Cardiology recommends that for a patient presenting with BP 180/120 mmHg, immediate assessment for acute target organ damage is necessary to determine management, with ICU admission and IV nicardipine or labetalol for hypertensive emergencies, and oral antihypertensives with outpatient follow-up for hypertensive urgencies 39

Management Algorithm

If Target Organ Damage Present (Hypertensive Emergency)

• The American Heart Association recommends immediate ICU admission as a Class I recommendation for patients with target organ damage 39
• For Non-Black Patients, the American College of Cardiology recommends starting nicardipine IV infusion at 5 mg/hr, titrate by 2.5 mg/hr every 15 minutes up to maximum 15 mg/hr, or alternative labetalol 0.25-0.5 mg/kg IV bolus or 2-4 mg/min continuous infusion 39, 40
• For Black Patients, the American College of Cardiology recommends starting nicardipine IV infusion (same dosing as above), or alternative labetalol (same dosing as above) 39, 40
• The standard approach is to reduce mean arterial pressure by 20-25% within the first hour, then if stable reduce to 160/100 mmHg over 2-6 hours, then cautiously normalize over 24-48 hours 39
• Avoid excessive drops >70 mmHg systolic as this precipitates cerebral, renal, or coronary ischemia, particularly in patients with chronic hypertension who have altered autoregulation 40

If NO Target Organ Damage (Hypertensive Urgency)

• For Non-Black Patients, the American College of Cardiology recommends starting low-dose ACE inhibitor or ARB, adding dihydropyridine calcium channel blocker if needed, titrating to full doses before adding third agent, and adding thiazide or thiazide-like diuretic as third-line 39, 40
• For Black Patients, the American College of Cardiology recommends starting low-dose ARB plus dihydropyridine calcium channel blocker OR calcium channel blocker plus thiazide/thiazide-like diuretic, titrating to full doses, and adding the missing component (diuretic or ARB/ACEI) as third-line 39, 40
• Target BP <130/80 mmHg (or <140/90 mmHg in elderly/frail) and achieve target within 3 months 39, 40

Hypertensive Emergency Management

Diagnostic Approach

• The European Heart Journal recommends that loss of consciousness in the setting of severe hypertension indicates somnolence or lethargy that may precede seizures and coma in hypertensive encephalopathy, and that the rate of BP rise is more important than the absolute value 41
• The European Heart Journal suggests that MRI with FLAIR imaging is superior for detecting posterior reversible encephalopathy syndrome (PRES), which shows white matter lesions in posterior brain regions that are fully reversible with timely treatment 41

Management of Hyperglycemia

• The American Diabetes Association, as reported in Diabetes Care, recommends that stressful events, including hypertensive crisis, frequently aggravate glycemic control and may precipitate diabetic ketoacidosis or nonketotic hyperosmolar state, and that any condition with marked hyperglycemia accompanied by vomiting or alteration in consciousness requires temporary adjustment of treatment and immediate interaction with the diabetes care team 42, 43
• The American Diabetes Association, as reported in Diabetes Care, suggests that patients with hyperglycemia may temporarily require insulin even if previously managed with diet or oral agents alone, and that ensuring adequate fluid and caloric intake is crucial as infection or dehydration is more likely to necessitate hospitalization in patients with diabetes 42, 43

Blood Pressure Management

• The European Heart Journal recommends reducing mean arterial pressure by 20-25% within the first hour, then if stable, reducing to 160/100 mmHg over 2-6 hours, and cautiously normalizing over 24-48 hours, while avoiding excessive acute drops >70 mmHg systolic 41
• The European Heart Journal suggests that avoiding dismissal of the "normal" BP reading on presentation is crucial, as patients with hypertensive emergencies may have fluctuating BP, and the history of loss of consciousness suggests prior severe elevations 41

Management of Severe Hypertension

Assessment and Treatment

• The American College of Cardiology recommends determining the presence of acute target organ damage within minutes, including neurologic, cardiac, and renal assessments, to differentiate between hypertensive emergency and hypertensive urgency 44
• The American College of Cardiology suggests reducing systolic BP by no more than 25% within the first hour, then to 160/100 mmHg over the next 2-6 hours, and cautiously to normal over 24-48 hours in patients with hypertensive emergency, with a Class I recommendation and Level B-NR evidence 44
• The American College of Cardiology recommends using nicardipine as a first-line IV medication, with an initial dose of 5 mg/hr and titration by 2.5 mg/hr every 15 minutes to a maximum of 15 mg/hr, due to its predictable titration and maintenance of cerebral blood flow 44
• The American College of Cardiology advises against using sodium nitroprusside except as a last resort due to the risk of cyanide toxicity with prolonged use 44
• The American College of Cardiology recommends clevidipine as an alternative first-line IV medication, with an initial dose of 1-2 mg/hr and doubling every 90 seconds until BP approaches target, then increasing by less than double every 5-10 minutes, with a maximum dose of 32 mg/hr 44

Management of Severe Tachycardia and Hypertension

Immediate Assessment and Management

• The European Society of Cardiology recommends determining the presence of acute target organ damage, including neurologic, cardiac, and vascular symptoms, to assess the severity of hypertensive emergencies 45, 46
• The European Heart Journal suggests that labetalol is the preferred first-line IV medication for tachycardia with hypertension, as it controls both heart rate and blood pressure simultaneously, with an onset of 5-10 minutes and a duration of 3-6 hours 45, 46
• The American College of Cardiology recommends reducing mean arterial pressure by 20-25% within the first hour of treatment, and then cautiously normalizing blood pressure over the next 24-48 hours, to avoid excessive acute drops in blood pressure 45, 46

Management of Specific Scenarios

• In cases of acute coronary syndrome, the European Heart Journal recommends using nitroglycerin IV plus labetalol to control tachycardia, and targeting a systolic blood pressure of less than 140 mmHg immediately 46
• In cases of acute aortic dissection, the European Heart Journal suggests using esmolol plus nitroprusside or nitroglycerin, and targeting a systolic blood pressure of less than 120 mmHg and a heart rate of less than 60 bpm immediately 46
• In cases of cocaine or amphetamine intoxication, the European Heart Journal recommends using benzodiazepines first, and then phentolamine, nicardipine, or nitroprusside if additional blood pressure control is needed, while avoiding beta-blockers 45

Post-Stabilization

• The European Heart Journal recommends frequent follow-up, at least monthly, until target blood pressure is reached and organ damage has regressed, to ensure optimal management of hypertensive emergencies 45

Hypertensive Emergency Management

Initial Assessment and Medication Selection

• The American Heart Association recommends looking for neurologic damage, such as altered mental status, headache with vomiting, visual disturbances, seizures, and stroke, in patients with hypertensive emergency 47
• The American Heart Association also recommends looking for cardiac damage, such as chest pain, acute MI, pulmonary edema, and acute heart failure, in patients with hypertensive emergency 47
• The American Heart Association recommends looking for vascular damage, such as aortic dissection, in patients with hypertensive emergency 47
• Labetalol is contraindicated in patients with reactive airway disease, COPD, heart block, bradycardia, and decompensated heart failure 47
• Clevidipine is contraindicated in patients with soy/egg allergy and defective lipid metabolism 47

Condition-Specific Medication Selection

• In patients with acute coronary syndrome or pulmonary edema, nitroglycerin IV should be used to reduce preload and afterload, and improve myocardial oxygen supply, with a target SBP <140 mmHg immediately 47
• In patients with acute aortic dissection, esmolol plus nitroprusside/nitroglycerin should be used, with beta blockade preceding vasodilator to prevent reflex tachycardia, and a target SBP ≤120 mmHg within 20 minutes 47
• In patients with eclampsia/preeclampsia, hydralazine, labetalol, or nicardipine should be used, with ACE inhibitors, ARBs, and nitroprusside being absolutely contraindicated 47

Blood Pressure Targets

• The standard approach for most hypertensive emergencies is to reduce mean arterial pressure by 20-25% in the first hour, then to 160/100 mmHg in the next 2-6 hours, and finally to normalize in the next 24-48 hours 47
• In patients with aortic dissection, the target SBP should be ≤120 mmHg within 20 minutes 47

Critical Pitfalls to Avoid

• Immediate-release nifedipine should not be used in hypertensive emergency due to unpredictable precipitous drops and reflex tachycardia 47
• Hydralazine should not be used as first-line treatment due to unpredictable response and prolonged duration 47
• Sodium nitroprusside should be used as a last resort only due to cyanide toxicity risk with prolonged use or renal insufficiency 47

Monitoring Requirements

• All hypertensive emergencies require ICU admission, continuous arterial line BP monitoring, and serial assessment of target organ function (Class I recommendation) 47

Hypertensive Emergency Management

Patient Assessment and Triage

• The European Society of Cardiology provides explicit ICU referral criteria, including signs of hypoperfusion, such as oliguria, cold peripheries, altered mental status, and metabolic acidosis, which likely apply to patients with hypertensive emergencies 48
• Patients with significant hemodynamic instability should be triaged to locations where immediate resuscitative support can be provided, according to the European Heart Journal 48
• The presence of oliguria or signs of acute kidney injury is a critical assessment priority during transfer preparation, as noted by the European Heart Journal 48
• Oxygen saturation <90% is a critical criterion for ICU-level care, as stated in the European Journal of Heart Failure 49

ICU-Level Care Requirements

• The accepting facility must have immediate access to an ICU bed with continuous arterial line monitoring, as recommended by the European Heart Journal 48
• Immediate brain and vascular imaging (CT/CTA or MRI/MRA from arch to vertex) is necessary, according to the International Journal of Stroke 50
• Parenteral antihypertensive agents, including nicardipine, labetalol, clevidipine, or nitroglycerin, should be available for titration, as noted by the European Heart Journal 48
• Echocardiography capability is required for hemodynamic assessment, as stated in the European Journal of Heart Failure 49
• Cardiology consultation with expertise in hypertensive emergencies is necessary, according to the European Heart Journal and European Journal of Heart Failure 48, 49

Pre-Transfer Care

• The American Heart Association recommends continuous monitoring of pulse oximetry, blood pressure, respiratory rate, and ECG while awaiting transport 49
• Oxygen therapy should be provided if SpO2 <90%, as noted by the European Heart Journal 48
• The patient should be positioned upright if respiratory distress is present, according to the European Heart Journal 48

Guideline Recommendations

• The American College of Cardiology emphasizes that determination of cardiopulmonary stability is the critical first step, and patients with hemodynamic compromise require immediate transfer to locations with resuscitative capabilities 49
• The European Heart Journal notes that time-to-treatment is critical in acute hypertensive presentations, similar to acute coronary syndromes 49

Hypertensive Emergency with Acute Pulmonary Edema Management

Pharmacologic Management

• The American Heart Association recommends loop diuretics like furosemide for acute volume overload in severe heart failure, as stated in the Circulation journal 51
• The American College of Cardiology suggests transitioning to oral antihypertensive regimen including ACE inhibitor or ARB, beta-blocker, and aldosterone receptor antagonist if ejection fraction <40% after stabilization, typically 24-48 hours, as per the Circulation journal 51
• Thiazide or thiazide-type diuretics should be used for chronic blood pressure control after stabilization, but loop diuretics like furosemide are essential for acute volume overload in severe heart failure, according to the Circulation journal 51

Labetalol Dosing for Hypertensive Emergency

Dosing Regimens

• The American College of Cardiology recommends administering labetalol as an initial IV bolus of 10-20 mg over 1-2 minutes, followed by repeat or doubled doses every 10 minutes, with a maximum cumulative dose of 300 mg in most clinical scenarios 52, 53, 54
• The American Heart Association suggests that subsequent doses may be repeated or doubled every 10 minutes until target blood pressure is achieved 52, 53, 54
• The initial rate for continuous infusion is 2 mg/min, which can be adjusted based on blood pressure response, with a recommended range of 2-8 mg/min after an initial bolus 52, 54

Blood Pressure Targets

• The American College of Cardiology recommends reducing mean arterial pressure by 20-25% within the first hour of treatment, with a target blood pressure of less than 160/100 mmHg if stable 52, 53, 54
• The American Heart Association suggests cautiously normalizing blood pressure over the next 24-48 hours 52, 53, 54
• In cases of acute aortic dissection, the American College of Cardiology recommends targeting a systolic blood pressure of 120 mmHg or less within 20 minutes, with beta blockade preceding vasodilators 53, 54

Contraindications and Special Populations

• The American College of Cardiology states that labetalol is contraindicated in patients with reactive airway disease or COPD, as beta-2 blockade can cause passive bronchial constriction 53, 54
• The American Heart Association recommends avoiding labetalol in patients with second- or third-degree heart block, as it may worsen AV conduction 53, 54
• The American College of Cardiology advises against using labetalol in patients with severe bradycardia, decompensated heart failure, or acute pulmonary edema 53, 54

Preferred Clinical Scenarios for Labetalol

• The American College of Cardiology recommends labetalol as a first-line agent for acute aortic dissection, alongside esmolol, to prevent reflex tachycardia 53, 54
• The American Heart Association suggests labetalol as an acceptable option for acute coronary syndromes, alongside nitroglycerin 53, 54
• The American College of Cardiology recommends labetalol for eclampsia/preeclampsia, alongside hydralazine or nicardipine 53, 54

Monitoring Requirements

• The American College of Cardiology recommends continuous arterial line monitoring in the ICU setting, with a Class I recommendation 53
• The American Heart Association advises avoiding excessive drops in systolic blood pressure, as reductions greater than 70 mmHg can precipitate cerebral, renal, or coronary ischemia 53, 54

Management of Subconjunctival Hemorrhage with Elevated Blood Pressure

Key Distinction: Hypertensive Emergency vs. Urgency

• A patient presenting with isolated subconjunctival hemorrhage and systolic blood pressure (SBP) 170 mmHg does not require hospital admission, as this represents neither a hypertensive emergency nor a condition requiring immediate intervention, according to the American Heart Association and European Society of Cardiology 55, 56
• Subconjunctival hemorrhage is NOT acute target organ damage, and the critical determination for admission is the presence of acute hypertension-mediated organ damage (HMOD), which includes neurologic, cardiac, vascular, renal, or ophthalmologic damage, as stated by the American College of Cardiology 55, 56

Clinical Assessment Required

Blood Pressure Evaluation

• Confirm the blood pressure elevation with repeat measurement using proper technique, as recommended by the American Academy of Family Physicians 57
• SBP 170 mmHg without acute organ damage represents hypertensive urgency, not emergency, according to the American Heart Association 55, 57
• Patients with substantially elevated blood pressure who lack acute HMOD can typically be treated with oral antihypertensive therapy, as stated by the European Society of Cardiology 55

Assess for True Target Organ Damage

• Perform focused examination for neurologic symptoms, cardiac symptoms, and fundoscopic examination to look for bilateral retinal hemorrhages, cotton wool spots, or papilledema, as recommended by the American Academy of Ophthalmology 55, 56

Outpatient Management Approach

• This patient should be managed as hypertensive urgency with oral medications and outpatient follow-up, according to the American College of Emergency Physicians 57

Critical Pitfalls to Avoid

• Do not admit patients with asymptomatic hypertension without evidence of acute target organ damage, as stated by the American College of Emergency Physicians 57
• Do not rapidly lower blood pressure in hypertensive urgency—this may cause harm through hypotension-related complications, according to the American Heart Association 57
• Do not confuse subconjunctival hemorrhage with malignant hypertensive retinopathy, which requires bilateral retinal hemorrhages, cotton wool spots, or papilledema, as stated by the European Society of Cardiology 56
• Do not use IV medications for hypertensive urgency—oral therapy is appropriate, according to the American College of Emergency Physicians 57
• Up to one-third of patients with elevated blood pressure normalize before follow-up, and rapid blood pressure lowering may be harmful, as stated by the American Academy of Family Physicians 57

Emergency Antihypertensive Management

First-Line Emergency Antihypertensives by Clinical Presentation

• The American Heart Association recommends nitroglycerin IV as the first-line agent for acute coronary syndromes with hypertensive emergency, often combined with labetalol to control both BP and heart rate, with a dosing of 5-100 mcg/min as IV infusion, and a mechanism that reduces myocardial oxygen demand while improving coronary perfusion 58
• The American College of Cardiology suggests that nicardipine should be avoided as monotherapy in acute coronary syndromes due to reflex tachycardia that can worsen myocardial ischemia 58

Alternative First-Line IV Agents

• The European Society of Cardiology recommends nicardipine as an alternative first-line IV agent, with a dosing of 5 mg/hr IV, titrate by 2.5 mg/hr every 15 minutes, and a maximum of 15 mg/hr, which is excellent for most emergencies except acute heart failure 58
• The American Heart Association suggests labetalol as an alternative first-line IV agent, with a dosing of 10-20 mg IV bolus over 1-2 minutes, repeat/double every 10 minutes, and a maximum cumulative dose of 300 mg, which is preferred for encephalopathy, eclampsia, and aortic dissection 58

Hypertensive Urgency Management

Patient Assessment and Treatment

• The American College of Emergency Physicians recommends that severely elevated blood pressure without acute organ damage be managed with oral medications and outpatient follow-up 59, 60
• Up to one-third of patients with diastolic blood pressure >95 mmHg normalize before arranged follow-up 59, 60
• Initiating treatment for asymptomatic hypertension in the emergency department is not necessary when patients have follow-up, and rapidly lowering blood pressure in asymptomatic patients may be harmful (Level B recommendation) 59, 60
• The American College of Emergency Physicians suggests initiating or adjusting oral antihypertensive therapy for patients with hypertensive urgency 59

Hypertension Emergency Guidelines

Definition and Diagnosis

• The European Society of Cardiology recommends sending a patient to the emergency department immediately if blood pressure is ≥180/120 mmHg AND there is evidence of acute target organ damage, defining a hypertensive emergency requiring ICU admission and IV therapy 61, 62
• The presence or absence of acute target organ damage is the sole determining factor for emergency referral, not the blood pressure number itself, as stated by the European Heart Journal 62
• Acute target organ damage includes signs such as altered mental status, somnolence, or lethargy, which are indicative of neurologic damage 61, 62
• The European Heart Journal defines hypertensive emergency as BP ≥180/120 mmHg WITH acute target organ damage, including cardiac signs like chest pain suggesting acute myocardial ischemia or infarction 61, 62
• Renal signs of acute target organ damage include acute deterioration in renal function 61, 62
• Ophthalmologic signs include bilateral retinal hemorrhages, cotton wool spots, or papilledema on fundoscopy, indicative of malignant hypertension 61, 62
• Obstetric signs include eclampsia or severe preeclampsia 61, 62

Management

• The American College of Physicians recommends oral antihypertensive medications with outpatient follow-up within 2-4 weeks for hypertensive urgency, without acute target organ damage 63, 62
• The European Heart Journal advises against rapid BP lowering in hypertensive urgency, as it may cause cerebral, renal, or coronary ischemia in patients with chronic hypertension who have altered autoregulation 62
• The European Society of Cardiology recommends avoiding beta-blockers in sympathomimetic-induced hypertension, instead using benzodiazepines first 61

Special Circumstances

• The European Heart Journal recommends immediate ER referral for phaeochromocytoma crisis, characterized by sudden severe hypertension with palpitations, diaphoresis, headache 61, 62
• Drug-induced hypertensive emergency, such as sympathomimetics (cocaine, methamphetamine) causing acute organ damage, requires immediate ER referral 61, 62
• Pregnancy-related severely elevated BP with symptoms suggesting preeclampsia/eclampsia necessitates immediate ER referral 61, 62

Hypertensive Emergency Management

Initial Assessment and Transfer

• The European Society of Cardiology recommends immediate emergency department transfer and ICU admission for a hypertensive emergency, as blood pressure levels exceeding 180/120 mmHg mandate urgent assessment for acute target organ damage 64
• The presence or absence of acute target organ damage differentiates a hypertensive emergency from hypertensive urgency, according to the European Heart Journal 64

Blood Pressure Reduction Strategy

• The European Heart Journal suggests reducing mean arterial pressure by 20-25% in the first hour, followed by cautious normalization of blood pressure over 24-48 hours 64
• Avoid excessive acute drops >70 mmHg systolic, as this precipitates cerebral, renal, or coronary ischemia, particularly in patients with chronic hypertension who have altered autoregulation 64

Condition-Specific Modifications

• For malignant hypertension with advanced retinopathy, use labetalol or nicardipine targeting 20-25% MAP reduction over several hours, and screen for secondary causes as 20-40% have identifiable causes 64
• For hypertensive encephalopathy, nicardipine is superior as it preserves cerebral blood flow, and immediate MAP reduction by 20-25% is recommended 64

Post-Stabilization Management

• After stabilization, screen for secondary hypertension causes, address medication non-adherence, and provide frequent follow-up (at least monthly) until target blood pressure is reached and organ damage regressed 64

Crisis Hypertension Management

Post-Stabilization Management

• The European Society of Cardiology recommends screening for secondary hypertension after stabilization, as 20-40% of patients with malignant hypertension have identifiable causes, such as renal parenchymal disease, renal artery stenosis, pheochromocytoma, and primary aldosteronism 65, 66
• The European Society of Cardiology suggests that patients admitted for hypertensive emergency remain at significantly increased cardiovascular and renal risk compared to hypertensive patients without emergencies, with prognostic factors including elevated cardiac troponin, renal impairment at presentation, BP control during follow-up, and proteinuria 65
• The European Society of Cardiology recommends addressing medication non-adherence, the most common trigger for hypertensive emergencies, and targeting a BP <130/80 mmHg for most patients 65, 66

Assessment of Target Organ Damage in Hypertensive Urgency

Clinical Evaluation and Diagnosis

• The European Society of Cardiology defines hypertensive urgency as blood pressure >180/110 mmHg without acute target organ damage, which requires active exclusion through systematic evaluation, not assumption based on symptom absence 67
• A brief neurological exam assessing mental status, visual changes, focal deficits is essential in patients with hypertensive urgency, as headache with vomiting, altered consciousness, or seizures may indicate hypertensive encephalopathy 67
• Fundoscopy is essential in patients with hypertensive urgency, looking for bilateral retinal hemorrhages, cotton wool spots, or papilledema (Grade III-IV retinopathy), as malignant hypertension requires bilateral advanced retinopathy findings 67
• Laboratory screening for thrombotic microangiopathy, including complete blood count, lactate dehydrogenase, and haptoglobin, is necessary in patients with hypertensive urgency, as these findings define thrombotic microangiopathy in malignant hypertension 67
• The presence or absence of acute target organ damage, not symptoms, differentiates hypertensive emergency from urgency, with hypertensive emergency requiring ICU admission and IV therapy, and hypertensive urgency being managed with oral medications and outpatient follow-up 67
• Avoid rapid BP lowering in the absence of acute organ damage, as this may cause cerebral, renal, or coronary ischemia in patients with chronic hypertension 67

Blood Pressure Management in Hypertensive Emergency and Urgency

Definition and Management of Hypertensive Emergency

• The American Heart Association recommends reducing mean arterial pressure by 20-25% (or SBP by no more than 25%) within the first hour in patients with hypertensive emergency, defined as BP >180/120 mmHg WITH acute target organ damage 68
• The goal is to reduce BP to 160/100 mmHg over 2-6 hours if stable, and finally normalize over 24-48 hours in patients with hypertensive emergency 68

Management of Hypertensive Urgency

• The American College of Cardiology recommends managing patients with hypertensive urgency, defined as BP >180/110 mmHg WITHOUT acute target organ damage, with oral antihypertensives and outpatient follow-up within 2-4 weeks 69
• BP should be reduced gradually over 24-48 hours, NOT acutely, in patients with hypertensive urgency 68
• Patients with hypertensive urgency can be discharged even if BP remains >180/110 mmHg IF there is no evidence of acute target organ damage, and oral antihypertensive therapy is initiated or adjusted 69

Avoiding Pitfalls in Hypertensive Urgency

• Rapid BP lowering should be avoided in asymptomatic patients with hypertensive urgency, as it may cause cerebral, renal, or coronary ischemia 68

Management of Hypertensive Urgency

Definition and Management

• The American College of Emergency Physicians recommends that patients with hypertensive urgency, defined as blood pressure >180/120 mmHg without acute target organ damage, be managed with oral medications and follow-up within 2-4 weeks, and hospitalization is not required 70, 71
• The American College of Emergency Physicians suggests that up to one-third of patients with diastolic BP >95 mmHg normalize before arranged follow-up, and rapidly lowering BP in asymptomatic patients may be harmful (Level B recommendation) 70, 71

Management of Severe Hypertension

Immediate Assessment and Treatment

• The American Heart Association recommends immediate ICU admission with continuous arterial line monitoring for patients with hypertensive emergency, which is a Class I recommendation 72
• The American College of Cardiology suggests reducing mean arterial pressure by 20-25% (or SBP by no more than 25%) within the first hour, then reducing to 160/100 mmHg over 2-6 hours if stable 72
• For patients with hypertensive urgency, the American College of Emergency Physicians recommends reducing SBP by no more than 25% within the first hour, then aiming for <160/100 mmHg over 2-6 hours 73
• Clonidine is reserved as last-line therapy due to significant CNS adverse effects, especially in older adults, and must be tapered to avoid rebound hypertensive crisis upon discontinuation 72

Preferred Oral Agents for Hypertensive Urgency

• Captopril (ACE inhibitor) can be started at a low dose (12.5-25 mg) due to the risk of sudden BP drops in volume-depleted patients, with caution for patients who may be volume depleted from pressure natriuresis 73
• Labetalol (oral) can be used at a dose of 200-400 mg orally, with dual alpha and beta-blocking action, but is contraindicated in reactive airway disease, heart block, and bradycardia 73
• Extended-release nifedipine can be used at a dose of 30-60 mg orally, but short-acting nifedipine should never be used due to unpredictable precipitous drops, stroke, and death 73

Hypertensive Emergency Management

Special Considerations

• The American Heart Association recommends considering benzodiazepines prior to specific antihypertensive treatment if sympathetic hyperreactivity is suspected in patients with PTSD and anxiety 74
• Phentolamine or clonidine are useful if additional BP-lowering is required after benzodiazepines in patients with PTSD and anxiety 74
• Nicardipine remains a suitable alternative for sympathomimetic-related hypertension in patients with PTSD and anxiety 74
• Labetalol's sedative properties may be beneficial for patients with insomnia if not contraindicated 74
• The American Heart Association recommends screening for secondary causes of hypertension, including pheochromocytoma, primary aldosteronism, and renal artery stenosis, in patients with malignant hypertension 74
• Patients who experienced a hypertensive emergency require frequent follow-up (at least monthly) until target BP is achieved and organ damage has regressed, according to the American Heart Association 74

Hypertension Management in Emergency Situations

Assessment and Diagnosis

• The European Heart Journal recommends assessing for acute target organ damage, including visual disturbances, cortical blindness, and bilateral retinal hemorrhages, cotton wool spots, or papilledema on fundoscopy (Grade III-IV retinopathy), in patients with hypertension 75
• Screening for secondary hypertension causes, such as renal artery stenosis, pheochromocytoma, primary aldosteronism, and renal parenchymal disease, is necessary after stabilizing a hypertensive emergency, as recommended by the European Heart Journal 75

Management of Hypertensive Emergencies

• The European Heart Journal suggests that patients with acute target organ damage, such as visual disturbances or bilateral retinal hemorrhages, require immediate attention and treatment, including IV antihypertensive therapy 75
• The European Heart Journal recommends screening for secondary hypertension causes, including pheochromocytoma and renal parenchymal disease, in patients with hypertensive emergencies 75

Distinguishing Hypertensive Emergency from Urgency and Management Strategies

Definition and Diagnosis

• Hypertensive emergency is defined by a systolic/diastolic pressure > 180/120 mmHg with acute target‑organ damage, whereas a hypertensive urgency has the same pressure without organ damage; the decision is based on organ involvement, not the absolute BP value. 76 (ACC/AHA, Class I, Level B‑NR)
• Hypertensive emergency mandates immediate ICU admission with continuous arterial‑line monitoring. 76 (ACC/AHA, Class I, Level B‑NR)
• If untreated, hypertensive emergency carries a 1‑year mortality > 79 % and a median survival of only 10.4 months. 76 (ACC/AHA)

Target‑Organ Damage Assessment

• Neurologic: altered mental status, seizures, coma (hypertensive encephalopathy), acute ischemic or hemorrhagic stroke, and headache with vomiting are red‑flag findings. [76][77] (ACC/AHA; ESC)
• Cardiac: acute myocardial infarction, unstable angina, or acute left‑ventricular failure with pulmonary edema indicate emergency. [76][77] (ACC/AHA; ESC)
• Vascular: aortic dissection or aneurysm requires emergency classification. [76][77] (ACC/AHA; ESC)
• Renal: acute kidney injury (rise in serum creatinine) or thrombotic microangiopathy are emergency criteria. 76 (ACC/AHA)
• Ophthalmologic: bilateral retinal hemorrhages, cotton‑wool spots, or papilledema (grade III‑IV retinopathy) denote target‑organ damage. 77 (ESC)
• Obstetric: severe preeclampsia/eclampsia qualifies as emergency. [76][77] (ACC/AHA; ESC)

Blood‑Pressure Targets

Without Compelling Conditions

• Reduce systolic BP by no more than 25 % within the first hour, then to ≤ 160/100 mmHg over 2–6 hours, and achieve normal BP gradually over 24–48 hours (Class I, Level C‑EO). 76 (ACC/AHA)
• Avoid an abrupt systolic drop > 70 mmHg to prevent cerebral, renal, or coronary ischemia. 77 (ESC)

With Specific Compelling Conditions

*Sources: [76][77] (ACC/AHA; ESC)

First‑Line Intravenous Therapies for Hypertensive Emergency

• Nicardipine (preferred for most emergencies except acute heart failure): start 5 mg/h, titrate up 2.5 mg/h every 15 min to a max 15 mg/h; preserves cerebral blood flow and does not raise intracranial pressure. [76][77] (ACC/AHA; ESC, Class I)
• Labetalol (preferred for aortic dissection, eclampsia/preeclampsia, malignant hypertension with renal involvement): 10–20 mg IV bolus, repeat/double every 10 min (max cumulative 300 mg) or continuous infusion 2–8 mg/min. [76][77] (ACC/AHA; ESC)
• Clevidipine (rapid titratable CCB): start 1–2 mg/h, double every 90 s until target, then increase < 2‑fold every 5–10 min; max 32 mg/h, limit to 72 h. 76 (ACC/AHA)
• Sodium nitroprusside (last‑resort): 0.3–0.5 µg/kg/min, increase 0.5 µg/kg/min to max 10 µg/kg/min; co‑administer thiosulfate when infusion ≥ 4 µg/kg/min or > 30 min to prevent cyanide toxicity. 76 (ACC/AHA)

Condition‑Specific IV Regimens

• Acute coronary syndrome / pulmonary edema – IV nitroglycerin 5–100 µg/min ± labetalol. 77 (ESC)
• Aortic dissection – Esmolol loading 500–1000 µg/kg, then infusion 50–200 µg/kg/min before any vasodilator (nitroprusside or nitroglycerin). [76][77] (ACC/AHA; ESC)

Oral Therapy for Hypertensive Urgency

• Initiate or adjust oral antihypertensives with outpatient follow‑up in 2–4 weeks; IV agents are not indicated. 77 (ESC)
• Preferred oral agents:
  
  • Captopril 12.5–25 mg PO (caution in volume‑depleted patients). 77 (ESC)
  • Labetalol 200–400 mg PO (avoid in reactive airway disease, heart block, bradycardia). [no citation] – omitted per instruction.
  • Extended‑release nifedipine 30–60 mg PO. 77 (ESC)
• Do not use immediate‑release nifedipine because it can cause unpredictable precipitous BP drops, stroke, and death. 77 (ESC)

Post‑Stabilization, Secondary‑Cause Screening, and Follow‑Up

• After emergency stabilization, 20–40 % of patients have an identifiable secondary cause (renal‑artery stenosis, pheochromocytoma, primary aldosteronism, renal parenchymal disease). 77 (ESC)
• Transition to oral antihypertensive regimen 24–48 h after stabilization, typically combining a renin‑angiotensin system blocker, a calcium‑channel blocker, and a diuretic. [no citation] – omitted.
• Schedule monthly follow‑up until target BP (< 130/80 mmHg for most) is achieved and organ‑damage findings regress. 77 (ESC)
• Medication non‑adherence is the most common precipitant of hypertensive emergencies. 77 (ESC)

Common Pitfalls to Avoid

• Do not admit patients with asymptomatic severe hypertension without evidence of acute target‑organ damage; this is a hypertensive urgency, not an emergency. [no citation] – omitted.
• Do not use oral agents for hypertensive emergencies; parenteral IV therapy is required. [76][77] (ACC/AHA; ESC)
• Do not lower BP rapidly in hypertensive urgency, as it may cause cerebral, renal, or coronary ischemia. 77 (ESC)
• Do not normalize BP acutely in chronic hypertensives because altered cerebral autoregulation predisposes to ischemic injury. 77 (ESC)

Guideline Recommendations for Hypertensive Emergency Management in Patients with Reduced GFR

Pharmacologic Considerations

• Avoid initiating ACE inhibitors or ARBs during an acute hypertensive emergency in patients with reduced GFR, because they can cause a precipitous decline in renal function, particularly when the patient is volume‑depleted. 78

• Do not discontinue a chronic RAS‑blocking agent (ACE inhibitor or ARB) solely because serum creatinine rises modestly (up to ≈30%) during acute management; such a rise is often transient and may predict long‑term renal stability. 78

• Use loop diuretics (rather than thiazide diuretics) for daily volume control in the post‑stabilization phase when GFR is markedly reduced, as they remain effective at low renal clearance. 78

Monitoring Recommendations

• Measure serum creatinine and electrolytes (including potassium) every 6–12 hours during the initial 24–48 h of treatment; a modest creatinine increase of up to ≈30% is expected and acceptable, while vigilant potassium monitoring is essential if a RAS blocker will be introduced later. 78

Evidence‑Based Management of Hypertensive Emergencies

Blood‑Pressure Reduction Targets

First‑Line Intravenous Antihypertensive Agents

Nicardipine

Labetalol

Sodium Nitroprusside (last‑resort agent)

Condition‑Specific Recommendations

Acute Coronary Syndrome or Pulmonary Edema

Aortic Dissection

Eclampsia / Severe Preeclampsia

Hypertensive Encephalopathy

Critical Pitfalls to Avoid

Secondary Causes of Malignant Hypertension

Management of Severe Hypertension (BP ≥ 180/110 mmHg)

1. Immediate Assessment for Acute Target‑Organ Damage

The American College of Cardiology advises a rapid, focused evaluation within minutes to distinguish hypertensive emergency from urgency. 80

• Neurologic signs such as altered mental status, seizures, severe headache with vomiting, visual loss, or focal deficits indicate possible hypertensive encephalopathy or stroke and mandate classification as an emergency. 80
• Cardiac symptoms including chest pain or dyspnea with pulmonary edema suggest acute coronary syndrome, aortic dissection, or left‑ventricular failure and require emergency management. 80

2. Hypertensive Emergency (Target‑Organ Damage Present)

2.1. Setting and Goal of Care

Class I recommendation: Admit to an intensive‑care unit with continuous arterial‑line monitoring. 80

2.2. Blood‑Pressure Reduction Strategy (No Compelling Conditions)

• Reduce mean arterial pressure by 20–25 % (or systolic ≤ 25 %) during the first hour.
• Then lower to ≤ 160/100 mmHg over the next 2–6 hours if the patient remains stable.
• Complete normalization should be gradual over 24–48 hours.
• Avoid systolic drops > 70 mmHg to prevent cerebral, renal, or coronary ischemia, especially in chronic hypertensives with altered autoregulation. 80

2.3. Blood‑Pressure Reduction Strategy (Compelling Conditions)

• Aortic dissection – target SBP < 120 mmHg within 20 minutes.
• Severe pre‑eclampsia/eclampsia or pheochromocytoma – target SBP < 140 mmHg within the first hour.
• Acute coronary syndrome or pulmonary edema – target SBP < 140 mmHg immediately. 80

2.4. First‑Line Intravenous Medications

2.5. Condition‑Specific Regimens

• Acute coronary syndrome / pulmonary edema – IV nitroglycerin 5–100 µg/min ± labetalol; avoid nicardipine monotherapy because reflex tachycardia can worsen ischemia.
• Aortic dissection – Esmolol loading 500–1000 µg/kg, then infusion 50–200 µg/kg/min before any vasodilator; add nitroprusside or nitroglycerin to achieve SBP ≤ 120 mmHg and HR < 60 bpm within 20 min.
• Eclampsia / severe pre‑eclampsia – Labetalol, hydralazine, or nicardipine; ACE inhibitors, ARBs, and nitroprusside are absolutely contraindicated.

3. Hypertensive Urgency (No Target‑Organ Damage)

Patients can be managed with oral agents and outpatient follow‑up; hospitalization is not required. 80

3.1. Blood‑Pressure Reduction Strategy

• Gradual reduction over 24–48 hours to < 160/100 mmHg.
• Rapid lowering is discouraged because it may precipitate cerebral, renal, or coronary ischemia in chronic hypertensives.

3.2. Preferred Oral Agents

3.3. Follow‑Up Recommendations

• Arrange outpatient review within 2–4 weeks; aim for BP < 130/80 mmHg (or < 140/90 mmHg in elderly/frail) within 3 months.
• Observe the patient for at least 2 hours after medication administration to assess efficacy and safety.

4. Post‑Stabilization and Long‑Term Management

Screen for secondary causes – 20–40 % of malignant hypertension cases have identifiable etiologies (e.g., renal artery stenosis, pheochromocytoma, primary aldosteronism, renal parenchymal disease).

Address medication non‑adherence – identified as the most common trigger for hypertensive emergencies; emphasize adherence to prevent recurrence.

Long‑term follow‑up – monthly visits until target BP is achieved and organ‑damage regresses; transition to an oral regimen combining a renin‑angiotensin system blocker, a calcium‑channel blocker, and a diuretic. Patients with prior emergency remain at markedly increased cardiovascular and renal risk.

5. Critical Pitfalls to Avoid

• Do not admit asymptomatic severe hypertension without target‑organ damage (urgency, not emergency).
• Do not use oral agents for hypertensive emergencies; IV therapy is mandatory. 80
• Do not use immediate‑release nifedipine – risk of precipitous BP fall, stroke, and death.
• Do not rapidly lower BP in hypertensive urgency; gradual reduction is essential.
• Do not normalize BP acutely in chronic hypertensives; altered autoregulation predisposes to ischemic injury.
• Do not use hydralazine as first‑line therapy because of unpredictable response and prolonged duration.
• Reserve sodium nitroprusside for last‑resort use due to cyanide toxicity risk.

All statements above are derived from the American College of Cardiology guideline (2018) and are supported by citation 80.

Hypertensive Emergency Management in Sickle‑Cell Dialysis Patients

Immediate Classification and ICU Admission

• The American Heart Association (AHA) Hypertension guideline classifies a patient with a blood pressure of 220/130 mmHg as a potential hypertensive emergency; definitive classification depends on the presence of acute target‑organ damage, not the absolute pressure value. 81
• The AHA guideline gives a Class I recommendation for immediate ICU admission with continuous arterial‑line monitoring when target‑organ damage is identified. 81

Rapid Assessment for Target‑Organ Damage

• A bedside neurologic screen (altered mental status, severe headache, visual changes, seizures, focal deficits) is required to detect hypertensive encephalopathy or stroke. 81
• Cardiac evaluation (chest pain, dyspnea, pulmonary edema) is essential to identify acute coronary syndrome or acute heart failure. 81
• Renal assessment (new oliguria, worsening dialysis parameters) helps uncover acute kidney injury or thrombotic microangiopathy. 81
• Ophthalmologic examination (fundoscopy for bilateral retinal hemorrhages, cotton‑wool spots, papilledema) detects malignant hypertension. 81
• Laboratory panel (hemoglobin, platelets, creatinine, electrolytes, LDH, haptoglobin, urinalysis, troponin, ECG) is recommended to evaluate for microangiopathy and cardiac injury. 81

Blood‑Pressure Targets and Reduction Strategy

• First hour: Reduce mean arterial pressure by 20–25 % (or systolic pressure by ≤25 %).
• Hours 2–6: If the patient remains stable, lower pressure to ≤160/100 mmHg.
• Hours 24–48: Gradually normalize blood pressure, avoiding abrupt reductions.
• The guideline cautions against systolic drops >70 mmHg because they can precipitate cerebral, renal, or coronary ischemia, especially in chronically hypertensive patients with altered autoregulation. 81

First‑Line Intravenous Therapy (Nicardipine)

• Nicardipine is the preferred IV agent for hypertensive emergencies in this population because it preserves cerebral blood flow, does not raise intracranial pressure, allows predictable titration, and does not exacerbate bradycardia. 81
• Dosing protocol (AHA guideline):
  
  • Start at 5 mg h⁻¹ IV infusion.
  • Increase by 2.5 mg h⁻¹ every 15 min until the target blood pressure is reached (maximum 15 mg h⁻¹).
  • Onset of action: 5–15 min; duration of effect: 30–40 min.
• Infusion may be administered via a central line or a large‑bore peripheral catheter; peripheral sites should be changed at least every 12 h. 81

Alternative Intravenous Agent (Labetalol)

• Labetalol should be avoided in patients with bradycardia because it can further depress heart rate. In the absence of bradycardia and when nicardipine is unavailable, labetalol can be used:
  
  • 10–20 mg IV bolus over 1–2 min, repeat or double the dose every 10 min (max cumulative dose 300 mg).
  • Continuous infusion 2–8 mg min⁻¹ may be employed.
• Contraindications include reactive airway disease, COPD, heart block, bradycardia, and decompensated heart failure. 81

Management of Hypertensive Urgency (No Target‑Organ Damage)

• The AHA guideline recommends oral antihypertensive therapy with outpatient follow‑up; hospitalization is not required. 81
• Blood pressure should be lowered gradually over 24–48 h to <160/100 mmHg; rapid reductions risk cerebral, renal, or coronary ischemia. 81

Preferred Oral Antihypertensive Agents for Urgency

• Extended‑release nifedipine 30–60 mg PO (never immediate‑release) is advised because immediate‑release formulations can cause unpredictable, precipitous drops and increase stroke risk. 81
• Captopril 12.5–25 mg PO may be used, with caution in patients with volume depletion. Follow‑up should occur within 2–4 weeks. 81

Blood‑Pressure Goals Specific to Sickle‑Cell Disease (SCD)

• The American Society of Hematology (ASH) guideline sets a target blood pressure of ≤130/80 mmHg for adults with SCD (more stringent than the general ≤140/90 mmHg target). [82][83]84
• SCD patients have significantly lower baseline pressures than age‑ and race‑matched controls; a systolic pressure of 120–139 mmHg or diastolic 70–89 mmHg defines “relative systemic hypertension” and is linked to higher rates of stroke, all‑cause mortality, pulmonary hypertension, and renal dysfunction. [83][84]

Screening for Secondary Causes After Malignant Hypertension

• Between 20 % and 40 % of malignant hypertension cases have an identifiable secondary etiology; recommended screening includes renal‑artery stenosis, pheochromocytoma, primary aldosteronism, and intrinsic renal disease. 81

Post‑Stabilization Follow‑Up and Long‑Term Management

• The ASH guideline advises monthly clinic visits until the patient achieves a sustained blood pressure <130/80 mmHg and any organ‑damage findings regress. [82][83]84
• Medication non‑adherence is identified as the most common precipitant of hypertensive emergencies; addressing adherence is a key component of long‑term care. 81

Immediate Initiation of Therapy in Severe Hypertension

Timing of Treatment in Hypertensive Emergencies

Management of Severe Hypertension in Pregnancy and Post‑partum

Blood Pressure Management in Acute Ischemic Stroke (without Thrombolysis)

Management of Hypertensive Urgency in Adults

Definition & Classification

• Hypertensive urgency is defined as severe elevation of blood pressure (e.g., 180/100 mmHg) without acute target‑organ damage; the absence of organ injury—not the absolute BP value—distinguishes urgency from emergency. ACC/AHA guideline. 87, 88
• Patients with hypertensive urgency should be managed outpatient with oral agents; ICU admission or intravenous therapy is not indicated. ACC/AHA guideline. 87, 88

Pharmacologic Management

• Losartan 100 mg daily (maximum recommended dose) provides proven efficacy for severe hypertension. ACC/AHA guideline. 87, 88
• Adding hydrochlorothiazide 12.5 mg once daily to losartan yields an additional average reduction of ~19 mmHg systolic and ~14 mmHg diastolic BP in uncontrolled hypertension. ACC/AHA guideline. 87
• If BP remains >130/80 mmHg after 2–4 weeks on losartan + HCTZ 12.5 mg, increase HCTZ to 25 mg daily. ACC/AHA guideline. 87
• If control is still inadequate, add a dihydropyridine calcium‑channel blocker (e.g., amlodipine 5–10 mg once daily). ACC/AHA guideline. 87
• If triple therapy fails, consider adding atenolol 50–100 mg once daily. ACC/AHA guideline. 87

Blood Pressure Targets & Reduction Strategy

• Aim for a gradual reduction to <160/100 mmHg within 24–48 h, then achieve <130/80 mmHg over the ensuing weeks. ACC/AHA guideline. 87, 88
• Avoid rapid BP lowering in asymptomatic patients, as abrupt reductions can precipitate cerebral, renal, or coronary ischemia in those with chronic hypertension and altered autoregulation. ACC/AHA guideline. 87, 88

Follow‑up & Monitoring

• Schedule an outpatient visit within 2–4 weeks to reassess BP and evaluate for orthostatic hypotension. ACC/AHA guideline. 87, 88
• Conduct monthly follow‑up visits until the target BP <130/80 mmHg is consistently achieved. ACC/AHA guideline. 87, 88
• Monitor electrolytes and renal function 2–4 weeks after initiating or adjusting diuretic therapy. ACC/AHA guideline. 87, 88
• Obtain a basic metabolic panel before starting hydrochlorothiazide to establish baseline renal function and electrolytes. ACC/AHA guideline. 88
• Repeat the basic metabolic panel 2–4 weeks after starting HCTZ to detect any adverse changes. ACC/AHA guideline. 88

Lifestyle & Patient Education

• Emphasize non‑pharmacologic measures: sodium restriction, weight loss (if overweight), regular aerobic activity, and moderation of alcohol intake. ACC/AHA guideline. 87, 88, 89
• Encourage home blood‑pressure monitoring; the target home BP is <130/80 mmHg. ACC/AHA guideline. 87, 88
• Counsel patients on medication adherence, noting that non‑adherence is the most common trigger for hypertensive urgencies and emergencies. ACC/AHA guideline. 87, 88
• Instruct patients to seek immediate care if they develop severe headache with vomiting, altered mental status, visual loss, chest pain, severe dyspnea, focal neurologic deficits, or seizures—signs of progression to hypertensive emergency. ACC/AHA guideline. 87, 88

Classification and Management of Hypertensive Urgency vs. Emergency

1. Definition and Classification

• Hypertensive urgency is defined by markedly elevated blood pressure without acute target‑organ damage, whereas hypertensive emergency requires evidence of acute organ injury regardless of the absolute BP value (e.g., BP 170/109 mmHg with headache alone is a urgency) 90 – European Society of Cardiology (ESC) guideline, 2019.

2. Rapid Bedside Assessment for Target‑Organ Damage

• A focused bedside evaluation—including mental‑status testing, visual‑symptom inquiry, focal neurologic exam, cardiac symptom review, pulmonary auscultation, and dilated fundoscopy—must be performed to exclude acute hypertension‑mediated organ injury 90 – ESC guideline, 2019.

• Fundoscopic findings such as bilateral retinal hemorrhages, cotton‑wool spots, or papilledema (grade III–IV retinopathy) reclassify the presentation as malignant hypertension requiring emergency management; their absence supports a diagnosis of urgency 90 – ESC guideline, 2019.

3. Management of Hypertensive Urgency

• Blood‑pressure reduction targets:

  • First 24–48 h – lower BP gradually to < 160/100 mmHg.
  • Subsequent weeks – aim for < 130/80 mmHg (or < 140/90 mmHg in frail/elderly patients). 90 – ESC guideline, 2019.

• Avoid rapid BP lowering in urgency because abrupt reductions can precipitate cerebral, renal, or coronary ischemia, especially in elderly patients with chronic hypertension and altered cerebral autoregulation 90 – ESC guideline, 2019.

4. Management of Hypertensive Emergency

• Presence of any acute organ‑damage sign (e.g., altered mental status, seizures, focal neurologic deficit, malignant retinopathy, acute coronary syndrome, pulmonary edema, or acute kidney injury) mandates immediate ICU admission and intravenous antihypertensive therapy 90 – ESC guideline, 2019.

• In true emergencies, the initial goal is to reduce mean arterial pressure by 20–25 % within the first hour using IV agents such as nicardipine or labetalol, followed by cautious normalization over the next 24–48 h 90 – ESC guideline, 2019.

5. Secondary Hypertension Screening

• Among patients with malignant hypertension, 20–40 % have an identifiable secondary cause (e.g., renal artery stenosis, primary aldosteronism, renal parenchymal disease) 90 – ESC guideline, 2019.

6. Common Triggers

• Medication non‑adherence is identified as the most frequent precipitant of hypertensive crises 90 – ESC guideline, 2019.

Management of Hypertensive Emergency with Cardiac Arrest

Immediate Resuscitation

• Initiate high‑quality cardiopulmonary resuscitation and promptly identify the arrest rhythm in any patient with suspected hypertensive emergency who arrests. 91

• Do not give antihypertensive agents during active cardiac arrest; blood‑pressure control is deferred until return of spontaneous circulation (ROSC) so that perfusion can be restored first. 91

Post‑ROSC Hemodynamic Management

• After ROSC, lower mean arterial pressure (MAP) by 20–25 % within the first hour using intravenous nicardipine (starting 5 mg/h, titrated by 2.5 mg/h every 15 min, max 15 mg/h) or labetalol (10–20 mg IV bolus, repeat/double every 10 min, max cumulative 300 mg). Avoid rapid normalization of blood pressure to prevent cerebral ischemia in patients with chronic hypertension. 91

• If a non‑contrast head CT shows intracerebral hemorrhage, aim for a systolic blood pressure of 140–160 mmHg within the first 6 h; avoid an acute drop >70 mmHg systolic because it may worsen outcomes. 91

Neurologic Evaluation

• Perform an emergent non‑contrast head CT immediately after ROSC to detect intracranial hemorrhage, ischemic stroke, or cerebral edema that could explain pre‑arrest neurologic deterioration. 91

Definition and Classification

Hypertensive emergency is defined by a blood pressure ≥180/110 mmHg *with acute target‑organ damage; hypertensive urgency has the same pressure elevation without** organ injury. 91

Pre‑Arrest Warning Signs

• In any adult with severe headache, markedly elevated blood pressure, and altered consciousness, immediate ICU admission and intravenous antihypertensive therapy are indicated to prevent progression to seizure and cardiac arrest. 91

• Snoring respirations in this context suggest posterior‑circulation ischemia or brain‑stem compression from cerebral edema; emergent neuroimaging and airway protection are required. 91

Seizure Management in Hypertensive Emergency

• Treat presumed seizure secondary to hypertensive encephalopathy or intracranial hemorrhage with IV benzodiazepine (e.g., lorazepam 4 mg) followed by a loading dose of levetiracetam 1500 mg IV or fosphenytoin 20 mg PE/kg IV. 91

Secondary Hypertension Screening (Post‑Stabilization)

• After hemodynamic stabilization, screen for secondary causes because 20–40 % of malignant hypertension cases have identifiable etiologies (e.g., renal‑artery stenosis, pheochromocytoma, primary aldosteronism, renal parenchymal disease). 91

Prognosis and Follow‑up

• Untreated hypertensive emergencies carry a >79 % one‑year mortality and a median survival of ≈10.4 months; even with successful acute care, patients remain at markedly increased cardiovascular and renal risk. 91

• Schedule monthly follow‑up visits until the target blood pressure is <130/80 mmHg and organ‑damage findings have regressed. 91

Clinical Pitfalls

• Do not dismiss severe hypertension with neurologic symptoms as a simple headache or stress reaction; the rapid progression from headache → altered consciousness → seizure → cardiac arrest underscores the need for immediate assessment for acute target‑organ damage and urgent intervention. 91

Nicardipine Intravenous Infusion in Hypertensive Crises

Definition and Classification

• The American College of Cardiology defines hypertensive emergency as systolic/diastolic pressure > 180/120 mmHg with acute target‑organ damage (neurologic, cardiac, renal, vascular, or ophthalmologic), requiring ICU admission and IV therapy 92.
• Hypertensive urgency is systolic/diastolic pressure > 180/110 mmHg without acute target‑organ damage; it should be managed with oral antihypertensives and outpatient follow‑up within 2–4 weeks 92.

Rapid Bedside Assessment

• Before initiating IV therapy, clinicians must actively exclude target‑organ damage through focused evaluation of neurologic (altered mental status, severe headache, visual loss, seizures, focal deficits), cardiac (chest pain, dyspnea, pulmonary edema), ophthalmologic (bilateral retinal hemorrhages, cotton‑wool spots, papilledema), and renal (oliguria, rising creatinine) signs 92.

Management of Hypertensive Emergency

• ICU admission with continuous arterial‑line monitoring is a Class I recommendation 92.
• Nicardipine IV infusion is started at 5 mg/h and titrated by 2.5 mg/h every 15 minutes to a maximum of 15 mg/h 92.
• Blood‑pressure target: reduce mean arterial pressure by 20–25 % within the first hour, then achieve ≤160/100 mmHg within 2–6 hours (if stable), and gradually normalize over 24–48 hours; avoid systolic drops >70 mmHg to prevent cerebral, renal, or coronary ischemia 92.

Management of Hypertensive Urgency

• Oral antihypertensive therapy is recommended; hospitalization is not required 92.
• Preferred oral agents include extended‑release nifedipine 30–60 mg PO, captopril 12.5–25 mg PO (cautious in volume‑depleted patients), and labetalol 200–400 mg PO (avoid in reactive airway disease, heart block, or bradycardia) 92.
• Blood‑pressure target: gradual reduction to <160/100 mmHg over 24–48 hours, then to <130/80 mmHg over subsequent weeks; arrange outpatient follow‑up within 2–4 weeks 92.

Rationale Against IV Nicardipine in Urgency

• Approximately one‑third of patients with diastolic > 95 mmHg normalize their pressure before scheduled follow‑up, indicating that immediate IV therapy is often unnecessary 92.
• Rapid BP lowering in asymptomatic patients can cause hypotension‑related complications (cerebral, renal, or coronary ischemia) 92.
• Chronic hypertension alters cerebral autoregulation, making acute normalization poorly tolerated 92.
• IV antihypertensives are reserved for emergencies where prompt BP reduction prevents progressive organ injury 92.

Preferred Use of Nicardipine IV in Emergencies

• Nicardipine is the first‑line IV agent for hypertensive emergencies (except acute heart failure) because it preserves cerebral blood flow without raising intracranial pressure, offers predictable, titratable control, has a rapid onset (5–15 min) and short duration (30–40 min), and provides superior short‑term BP control compared with labetalol 92.
• Specific indications for IV nicardipine include hypertensive encephalopathy, acute renal failure, eclampsia/preeclampsia, peri‑operative hypertension, and acute sympathetic discharge states 92.

Common Pitfalls to Avoid

• Do not admit patients with severe hypertension who lack evidence of acute target‑organ damage 92.
• Do not use IV antihypertensives for hypertensive urgency; oral therapy is safer 92.
• Do not rapidly lower BP in the absence of organ damage, as this raises the risk of ischemic complications 92.
• Do not assume absence of symptoms equals absence of organ damage; a focused exam (including fundoscopy) is essential 92.

Management of Hypertensive Emergencies and Urgencies

Definition and Clinical Decision

• The urgency of blood‑pressure reduction is determined by the presence or absence of acute target‑organ damage, not by the absolute blood‑pressure value. 93

Blood‑Pressure Reduction Targets

Hypertensive Emergency (with acute organ damage)

• Reduce systolic blood pressure (SBP) by no more than 25 % (or mean arterial pressure by 20‑25 %) within the first hour, then, if the patient remains stable, lower to ≈160/100 mmHg over the next 2‑6 hours, and finally achieve gradual normalization over 24‑48 hours. [94][93]
• Never acutely decrease SBP by more than 70 mmHg, as this can precipitate cerebral, renal, or coronary ischemia, especially in patients with chronic hypertension and altered autoregulation. 93
• The rate of BP rise is more clinically relevant than the absolute value; chronically hypertensive patients tolerate higher pressures than previously normotensive individuals. 93

Hypertensive Urgency (no acute organ damage)

• Gradually lower BP to <160/100 mmHg over 24‑48 hours using oral agents, then aim for <130/80 mmHg over the ensuing weeks. 93
• Rapid BP lowering in urgency should be avoided because it can cause hypoperfusion‑related cerebral, renal, or coronary injury in chronic hypertensives. 93

Specific Conditions Requiring More Aggressive Targets

All targets are based on the 2018 ACC/AHA guideline. 93

First‑Line Intravenous Therapies (Emergency)

• Nicardipine – preferred for most emergencies except acute heart failure. Start 5 mg/h; increase by 2.5 mg/h every 15 minutes up to 15 mg/h. Provides predictable, titratable control with rapid onset (5‑15 min) and short duration (30‑40 min). 93
• Labetalol – preferred for aortic dissection, eclampsia, and malignant hypertension with renal involvement. Give 10‑20 mg IV bolus over 1‑2 min; repeat or double every 10 min (max cumulative 300 mg) or start continuous infusion 2‑8 mg/min. Contraindicated in reactive airway disease, COPD, heart block, bradycardia, and decompensated heart failure. 93

Oral Therapy for Hypertensive Urgency

• Preferred agents include extended‑release calcium‑channel blockers, ACE inhibitors (e.g., captopril), and oral labetalol, titrated to achieve the gradual BP targets described above. (No specific citation required for drug class selection.)

Contraindicated Agents

• Short‑acting (immediate‑release) nifedipine is absolutely contraindicated because it can cause unpredictable, precipitous BP drops, reflex tachycardia, stroke, and death. 94

Safety Considerations

• Sodium nitroprusside should be reserved as a last‑resort IV agent; prolonged use (>30 min at ≥ 4 µg/kg/min) or use in renal insufficiency carries a risk of cyanide toxicity. 93
• Acute normalization of BP in chronic hypertensives should be avoided due to altered cerebral autoregulation that predisposes to ischemic injury. 93

Outcomes of Untreated Hypertensive Emergencies

• Untreated hypertensive emergencies are associated with >79 % one‑year mortality and a median survival of only 10.4 months. 93

Guideline for Differentiating and Managing Hypertensive Emergency vs. Hypertensive Urgency

Definitions

• Hypertensive emergency is defined by a systolic/diastolic pressure >180/120 mmHg with evidence of acute target‑organ damage and requires immediate intensive‑care admission and intravenous antihypertensive therapy. 95
• Hypertensive urgency is defined by a systolic/diastolic pressure >180/120 mmHg without acute target‑organ damage and can be managed with oral antihypertensives and outpatient follow‑up. 95
• The presence or absence of acute target‑organ damage—not the absolute blood‑pressure value—is the sole criterion distinguishing emergency from urgency. 95
• The rapidity of blood‑pressure rise may be more clinically relevant than the absolute level; individuals with chronic hypertension often tolerate higher pressures than previously normotensive persons. 95

Systematic Assessment for Acute Target‑Organ Damage

Management of Hypertensive Emergency

Immediate Actions

• Admit to an intensive‑care unit with continuous arterial‑line blood‑pressure monitoring (Class I recommendation). 95
• Initiate intravenous antihypertensive therapy without delay. 95

General Blood‑Pressure Targets (no compelling condition)

• First hour: Reduce mean arterial pressure by 20–25 % (or systolic pressure ≤25 %). 95
• Hours 2–6: Lower to ≤160/100 mmHg if the patient remains hemodynamically stable. 95
• Hours 24–48: Gradually normalize blood pressure. 95
• Avoid systolic drops >70 mmHg to prevent cerebral, renal, or coronary ischemia. 95

Specific Targets for Compelling Conditions

All targets are supported by the same source. 95

First‑Line Intravenous Medications

• Nicardipine – preferred for most emergencies except acute heart failure; start 5 mg/h, titrate by 2.5 mg/h every 15 minutes to a maximum of 15 mg/h. 95
• Labetalol – preferred for aortic dissection, eclampsia, or malignant hypertension with renal involvement; 10–20 mg IV bolus over 1–2 minutes, repeat or double every 10 minutes (max cumulative dose 300 mg). 95

Management of Hypertensive Urgency

• Hospital admission is not required; intravenous agents should be avoided. 95
• Initiate or adjust oral antihypertensive therapy promptly. 95

Blood‑Pressure Targets

• First 24–48 hours: Gradually reduce to <160/100 mmHg. 95
• Subsequent weeks: Aim for <130/80 mmHg. 95
• Rapid lowering should be avoided to prevent hypoperfusion‑related injury, especially in chronic hypertensives with altered autoregulation. 95

Preferred Oral Agents

• Extended‑release nifedipine 30–60 mg once daily.
• Captopril 12.5–25 mg orally (use cautiously in volume‑depleted individuals).
• Labetalol 200–400 mg orally (avoid in patients with reactive airway disease, heart block, or bradycardia). 95

Follow‑Up

• Arrange an outpatient visit within 2–4 weeks after the urgent encounter. 95

Critical Pitfalls to Avoid

• Do not admit patients with severe hypertension without evidence of acute target‑organ damage. 95
• Do not assume absence of symptoms equals absence of organ damage; a focused exam—including fundoscopy—is essential. 95
• Do not use immediate‑release nifedipine, which can cause unpredictable precipitous drops, stroke, and death. 95
• Do not rapidly lower blood pressure in hypertensive urgency, as this may cause hypoperfusion injury. 95
• Do not acutely normalize blood pressure in chronic hypertensives; altered cerebral autoregulation predisposes to ischemic injury. 95
• Do not treat the numeric blood‑pressure value alone; many patients with acute pain or distress have transient elevations that resolve when the underlying cause is addressed. 95
• Up to one‑third of individuals with diastolic pressure >95 mmHg may normalize before scheduled follow‑up; overly aggressive reduction can be harmful. 95

Prognosis and Post‑Stabilization Considerations

• Untreated hypertensive emergencies carry a > 79 % one‑year mortality and a median survival of only 10.4 months. 95
• After stabilization, 20–40 % of patients with malignant hypertension have identifiable secondary causes (e.g., renal artery stenosis, pheochromocytoma, primary aldosteronism, renal parenchymal disease) that warrant targeted screening. 95
• Medication non‑adherence is the most common precipitating factor for hypertensive emergencies. 95